nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—peripheral nervous system—amyotrophic lateral sclerosis	0.0564	0.197	CbGeAlD
Ingenol Mebutate—PRKCA—nerve—amyotrophic lateral sclerosis	0.044	0.153	CbGeAlD
Ingenol Mebutate—PRKCA—hindbrain—amyotrophic lateral sclerosis	0.0329	0.115	CbGeAlD
Ingenol Mebutate—PRKCA—embryo—amyotrophic lateral sclerosis	0.0206	0.0719	CbGeAlD
Ingenol Mebutate—PRKCA—brainstem—amyotrophic lateral sclerosis	0.0189	0.0659	CbGeAlD
Ingenol Mebutate—PRKCD—nervous system—amyotrophic lateral sclerosis	0.0179	0.0626	CbGeAlD
Ingenol Mebutate—PRKCD—central nervous system—amyotrophic lateral sclerosis	0.0173	0.0603	CbGeAlD
Ingenol Mebutate—PRKCD—cerebellum—amyotrophic lateral sclerosis	0.0169	0.0589	CbGeAlD
Ingenol Mebutate—PRKCD—brain—amyotrophic lateral sclerosis	0.0137	0.0478	CbGeAlD
Ingenol Mebutate—PRKCA—spinal cord—amyotrophic lateral sclerosis	0.0117	0.041	CbGeAlD
Ingenol Mebutate—PRKCA—nervous system—amyotrophic lateral sclerosis	0.00989	0.0345	CbGeAlD
Ingenol Mebutate—PRKCA—central nervous system—amyotrophic lateral sclerosis	0.00952	0.0332	CbGeAlD
Ingenol Mebutate—PRKCA—cerebellum—amyotrophic lateral sclerosis	0.00931	0.0325	CbGeAlD
Ingenol Mebutate—PRKCA—brain—amyotrophic lateral sclerosis	0.00756	0.0264	CbGeAlD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00175	0.00246	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.00175	0.00245	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.00174	0.00243	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.00173	0.00242	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00171	0.00239	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IGFBP3—amyotrophic lateral sclerosis	0.00171	0.00239	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TPK1—amyotrophic lateral sclerosis	0.00169	0.00237	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00165	0.00232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cardiac Hypertrophic Response—IGF1—amyotrophic lateral sclerosis	0.00165	0.00232	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—VEGFA—amyotrophic lateral sclerosis	0.00164	0.0023	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00163	0.00229	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—RTN4—amyotrophic lateral sclerosis	0.00163	0.00229	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.0016	0.00224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFR2 mediated cell proliferation—VEGFA—amyotrophic lateral sclerosis	0.00159	0.00222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—amyotrophic lateral sclerosis	0.00159	0.00222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00158	0.00222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00158	0.00221	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.00157	0.00221	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.00157	0.00219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00156	0.00219	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00155	0.00217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00153	0.00215	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00152	0.00213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.00148	0.00207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.00147	0.00206	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00144	0.00202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00144	0.00202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—CASP9—amyotrophic lateral sclerosis	0.00142	0.00199	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.00141	0.00197	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00139	0.00195	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00139	0.00195	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—ATF1—amyotrophic lateral sclerosis	0.00138	0.00194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.00138	0.00194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00138	0.00194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—PFN1—amyotrophic lateral sclerosis	0.00138	0.00194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—CASP9—amyotrophic lateral sclerosis	0.00136	0.00191	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—VTA1—amyotrophic lateral sclerosis	0.00135	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—p53 pathway—TP53—amyotrophic lateral sclerosis	0.00134	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00134	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00134	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—ATF1—amyotrophic lateral sclerosis	0.00134	0.00187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—APOE—amyotrophic lateral sclerosis	0.00129	0.00181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.00129	0.00181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—CASP9—amyotrophic lateral sclerosis	0.00128	0.00179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—CASP9—amyotrophic lateral sclerosis	0.00127	0.00178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—CASP9—amyotrophic lateral sclerosis	0.00127	0.00178	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00126	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00126	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—CASP9—amyotrophic lateral sclerosis	0.00126	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.00124	0.00174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.00122	0.00171	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.0012	0.00169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0012	0.00168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—CASP9—amyotrophic lateral sclerosis	0.00119	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—CASP9—amyotrophic lateral sclerosis	0.00119	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—CASP9—amyotrophic lateral sclerosis	0.00118	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00117	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00117	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.00117	0.00164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—ERBB4—amyotrophic lateral sclerosis	0.00116	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—CASP9—amyotrophic lateral sclerosis	0.00116	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—CASP9—amyotrophic lateral sclerosis	0.00116	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00114	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00112	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00111	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00111	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00111	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—VEGFA—amyotrophic lateral sclerosis	0.0011	0.00155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.0011	0.00155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.0011	0.00154	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—ERBB4—amyotrophic lateral sclerosis	0.00109	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—ERBB4—amyotrophic lateral sclerosis	0.00109	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.00108	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	0.00108	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00105	0.00148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—CASP9—amyotrophic lateral sclerosis	0.00105	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00105	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	0.00104	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.00104	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—TP53—amyotrophic lateral sclerosis	0.00103	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00103	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.00103	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	0.00101	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—ERBB4—amyotrophic lateral sclerosis	0.00101	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.00101	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.000997	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000996	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000996	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.000993	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000981	0.00137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TPK1—amyotrophic lateral sclerosis	0.000972	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000967	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000958	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00095	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000947	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000946	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—VEGFA—amyotrophic lateral sclerosis	0.000944	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000941	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PLB1—amyotrophic lateral sclerosis	0.000927	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000918	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—amyotrophic lateral sclerosis	0.000911	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000907	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.000904	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.000899	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000898	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000891	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—TP53—amyotrophic lateral sclerosis	0.000866	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000848	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000846	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.000843	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000842	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000833	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000828	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—VCP—amyotrophic lateral sclerosis	0.000827	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000819	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000814	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000814	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000808	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000802	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000799	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000799	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000798	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—VTA1—amyotrophic lateral sclerosis	0.000777	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000762	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000745	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000744	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000726	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000717	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000714	0.001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000692	0.00097	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000691	0.000969	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000691	0.000968	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000687	0.000962	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000675	0.000946	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000653	0.000916	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000653	0.000915	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000651	0.000912	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000649	0.00091	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—VEGFA—amyotrophic lateral sclerosis	0.000634	0.000889	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—amyotrophic lateral sclerosis	0.00062	0.000869	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000618	0.000866	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000611	0.000856	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00061	0.000856	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	0.000598	0.000839	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CST3—amyotrophic lateral sclerosis	0.000593	0.000832	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—amyotrophic lateral sclerosis	0.000593	0.000831	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000592	0.00083	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000589	0.000826	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000589	0.000825	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000581	0.000815	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000579	0.000811	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000571	0.0008	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000566	0.000793	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000561	0.000786	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—RARA—amyotrophic lateral sclerosis	0.00055	0.000771	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000543	0.000761	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PLB1—amyotrophic lateral sclerosis	0.000533	0.000747	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000527	0.000739	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000523	0.000733	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000506	0.00071	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000498	0.000698	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—amyotrophic lateral sclerosis	0.000498	0.000698	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000492	0.00069	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ATF1—amyotrophic lateral sclerosis	0.000491	0.000688	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000488	0.000683	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000484	0.000678	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000479	0.000671	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—VCP—amyotrophic lateral sclerosis	0.000475	0.000666	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—DCTN1—amyotrophic lateral sclerosis	0.00047	0.000659	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00047	0.000659	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CASP9—amyotrophic lateral sclerosis	0.000467	0.000655	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000461	0.000646	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000459	0.000644	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000446	0.000625	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000443	0.000621	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CASP9—amyotrophic lateral sclerosis	0.000431	0.000605	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000412	0.000577	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000412	0.000577	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000412	0.000577	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.0004	0.000561	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB4—amyotrophic lateral sclerosis	0.0004	0.000561	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000399	0.000559	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000394	0.000553	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000376	0.000527	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000373	0.000523	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB4—amyotrophic lateral sclerosis	0.000369	0.000518	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000364	0.00051	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000363	0.000508	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000355	0.000497	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000351	0.000492	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000343	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CST3—amyotrophic lateral sclerosis	0.000341	0.000478	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.00034	0.000477	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000338	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000338	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000332	0.000466	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—C3—amyotrophic lateral sclerosis	0.000332	0.000466	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000328	0.000459	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000322	0.000451	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000318	0.000446	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000317	0.000445	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000302	0.000423	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000301	0.000422	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.0003	0.000421	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000286	0.000401	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—APOE—amyotrophic lateral sclerosis	0.000286	0.0004	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000283	0.000396	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ATF1—amyotrophic lateral sclerosis	0.000282	0.000395	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.00028	0.000392	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CASP9—amyotrophic lateral sclerosis	0.000268	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000259	0.000362	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CASP9—amyotrophic lateral sclerosis	0.000248	0.000347	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000243	0.000341	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000241	0.000337	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000236	0.000331	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00023	0.000322	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB4—amyotrophic lateral sclerosis	0.00023	0.000322	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000216	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000215	0.000301	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB4—amyotrophic lateral sclerosis	0.000212	0.000297	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000209	0.000293	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.0002	0.00028	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—amyotrophic lateral sclerosis	0.000196	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000194	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—C3—amyotrophic lateral sclerosis	0.000191	0.000268	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000183	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000182	0.000255	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000182	0.000255	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000174	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000167	0.000234	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000165	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOE—amyotrophic lateral sclerosis	0.000164	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000149	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00014	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000138	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOE—amyotrophic lateral sclerosis	0.000137	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.00013	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000127	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000123	0.000173	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.00012	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000115	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—amyotrophic lateral sclerosis	0.000112	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000108	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.49e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.41e-05	0.000132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.16e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.31e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.9e-05	9.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.2e-05	8.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.68e-05	6.57e-05	CbGpPWpGaD
